These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36241021)

  • 1. Open Modification Searching of SARS-CoV-2-Human Protein Interaction Data Reveals Novel Viral Modification Sites.
    Adams C; Boonen K; Laukens K; Bittremieux W
    Mol Cell Proteomics; 2022 Dec; 21(12):100425. PubMed ID: 36241021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
    Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
    J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
    Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
    J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
    Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
    mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein post-translational modification in SARS-CoV-2 and host interaction.
    Cheng N; Liu M; Li W; Sun B; Liu D; Wang G; Shi J; Li L
    Front Immunol; 2022; 13():1068449. PubMed ID: 36713387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
    Zhang H; Zheng H; Zhu J; Dong Q; Wang J; Fan H; Chen Y; Zhang X; Han X; Li Q; Lu J; Tong Y; Chen Z
    J Proteome Res; 2021 May; 20(5):2224-2239. PubMed ID: 33666082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Post-Translational SUMOylation Modification of SARS-CoV-2 Nucleocapsid Protein Enhances Its Interaction Affinity with Itself and Plays a Critical Role in Its Nuclear Translocation.
    Madahar V; Dang R; Zhang Q; Liu C; Rodgers VGJ; Liao J
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins ‒ A new frontier.
    Mishra S; Bassi G; Nyomba BG
    Exp Biol Med (Maywood); 2021 Apr; 246(7):749-757. PubMed ID: 33467896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells.
    Basu A; Penumutchu S; Nguyen K; Mbonye U; Tolbert BS; Karn J; Komar AA; Mazumder B
    J Virol; 2022 Jan; 96(2):e0167821. PubMed ID: 34757848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alignment of virus-host protein-protein interaction networks by integer linear programming: SARS-CoV-2.
    Llabrés M; Valiente G
    PLoS One; 2020; 15(12):e0236304. PubMed ID: 33284827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
    J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global succinylation of SARS-CoV-2-infected host cells reveals drug targets.
    Liu Q; Wang H; Zhang H; Sui L; Li L; Xu W; Du S; Hao P; Jiang Y; Chen J; Qu X; Tian M; Zhao Y; Guo X; Wang X; Song W; Song G; Wei Z; Hou Z; Wang G; Sun M; Li X; Lu H; Zhuang X; Jin N; Zhao Y; Li C; Liao M
    Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2123065119. PubMed ID: 35858407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
    Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
    Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus-Host Interactions.
    Kakkanas A; Karamichali E; Koufogeorgou EI; Kotsakis SD; Georgopoulou U; Foka P
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of N6-methyladenosine RNA modification in regulation of SARS-CoV-2 infection and virus-host interactions.
    Liu J; Chen L; Guo X; Zhao B; Jiang J
    Biomed Pharmacother; 2024 Apr; 173():116231. PubMed ID: 38484561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
    Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
    Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.